Hormel Foods Corporation logo

Hormel Foods Corporation (HRL)

Market Closed
20 Jul, 20:00
NYSE NYSE
$
25. 28
-0.11
-0.4332%
$
13.84B Market Cap
21.43 P/E Ratio
4.29% Div Yield
2.81M Volume
1.62 Eps
$ 25.39
Previous Close
Add Transaction
Day Range
25.11 25.39
Year Range
19.7 29.78
Want to track HRL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hormel Foods (HRL) Surpasses Q1 Earnings and Revenue Estimates

Hormel Foods (HRL) Surpasses Q1 Earnings and Revenue Estimates

Hormel Foods (HRL) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.35 per share a year ago.

Zacks | 4 months ago
Hormel Posts Higher Profit, Sales Amid Turnaround

Hormel Posts Higher Profit, Sales Amid Turnaround

Hormel Foods logged higher profit and revenue in its fiscal first quarter, as the steps it has taken to improve profitability are starting to yield results.

Wsj | 4 months ago
Hormel Foods Gears Up for Q1 Earnings: Key Insights for Investors

Hormel Foods Gears Up for Q1 Earnings: Key Insights for Investors

HRL's first-quarter results are likely to show modest sales growth, but elevated beef costs and turkey constraints may pressure earnings.

Zacks | 4 months ago
How HRL Is Reshaping Its Portfolio to Support Long-Term Growth

How HRL Is Reshaping Its Portfolio to Support Long-Term Growth

Hormel Foods is reshaping its portfolio with a strategic divestiture to boost profitability and focus on value-added protein offerings.

Zacks | 5 months ago
Hormel Foods Corporation (HRL) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript

Hormel Foods Corporation (HRL) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript

Hormel Foods Corporation (HRL) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript

Seekingalpha | 5 months ago
Hormel Foods Posts Q1 Preliminary Results: What Lies Ahead?

Hormel Foods Posts Q1 Preliminary Results: What Lies Ahead?

HRL posts Q1 prelim sales of $3 billion with 2% organic growth and reaffirms fiscal 2026 outlook as it advances protein-focused strategy.

Zacks | 5 months ago
HRL's Pricing and Cost Actions to Support Margins in FY26

HRL's Pricing and Cost Actions to Support Margins in FY26

Hormel Foods sees improving earnings visibility into fiscal 2026 as pricing actions, cost cuts and efficiency gains begin to offset recent headwinds.

Zacks | 5 months ago
Insights Into Hormel (HRL) Q1: Wall Street Projections for Key Metrics

Insights Into Hormel (HRL) Q1: Wall Street Projections for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Hormel (HRL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2026.

Zacks | 5 months ago
Hormel Foods Corporation (HRL) Shareholder/Analyst Call Transcript

Hormel Foods Corporation (HRL) Shareholder/Analyst Call Transcript

Hormel Foods Corporation (HRL) Shareholder/Analyst Call Transcript

Seekingalpha | 5 months ago
Hormel Foods International Sales: Still a Growth Engine?

Hormel Foods International Sales: Still a Growth Engine?

HRL's International business highlights pockets of growth, with branded products gaining traction despite ongoing regional market challenges.

Zacks | 6 months ago
Consumer Staples Are Exploding Higher in 2026: Buy 5 High-Yielding Dividend Kings Now

Consumer Staples Are Exploding Higher in 2026: Buy 5 High-Yielding Dividend Kings Now

Consumer staples underperformed in a big way in 2025 but may see a more favorable environment in 2026 with easing sector-specific pressures and fiscal stimulus potentially boosting demand.

247wallst | 6 months ago
Hormel Foods: Dividend King That's Too Cheap To Ignore At Decade Lows

Hormel Foods: Dividend King That's Too Cheap To Ignore At Decade Lows

Hormel Foods is rated a Buy, trading near decade lows with a ~5% dividend yield and strong fundamentals. HRL targets 2–3% organic net sales growth and 5–7% operating income growth long-term, supported by portfolio optimization and protein focus. Free cash flow is expected to normalize following elevated CAPEX and inventory build-up in 2025, with the valuation estimating their fair value above current levels.

Seekingalpha | 6 months ago
Loading...
Load More